Home›Companies›Artificial Intelligence›Nodes Bio

Nodes Bio, Inc.

Nodes Bio helps researchers and medical professionals compare AI answers, map biology and summarize personal medical records.

Updated Nov 19, 2026·Latest SEC filing Nov 19, 2026·Suggest an edit

About Nodes Bio

Nodes Bio makes software for researchers, medical professionals and people reviewing their own health records. Its tools compare answers from several AI systems, draw biological pathways and explain medical information. Jarvis queries five AI models and combines their responses into one answer with a confidence score. MedMap turns plain-English biology into publication-ready diagrams. Health creates plain-language summaries through an existing MyChart login, without an account or storing records on Nodes Bio servers. The Apple catalog also lists Nexus Research: 5 AI Consensus. The platform targets professional researchers and biotech developers, although students may use it to understand course concepts.

Nodes Bio was founded in 2025 and is based in Columbus, Ohio. John Muirhead-Gould is its founder, executive officer and a director. Christina Murihead-Gould is a director. Users retain ownership of uploaded research and resulting discoveries or inventions. They may publish, patent or commercialize their work. Nodes Bio charges for its software rather than claiming rights to user intellectual property. Researcher outreach targets NIH-funded labs at Harvard, Yale and Duke. It also targets Biogen and the Broad Institute.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 9, 2026Nov 19, 2026$11,500target not set5$2,300Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nodes Bio's Form D filed Nov 19, 2026.

JG
John Muirhead-Gould
Executive Officer and Director

Why Investors Backed Nodes Bio

Nodes Bio targets uncertainty from relying on a single AI model in medical work. It reached commercial launch after an 11-year patent journey and gained a paying customer during the Rev1 Ventures accelerator. [1][3]

Origin and Team

John Muirhead-Gould is Nodes Bio's founder. Nodes Bio is a Delaware C corporation founded in 2025. [3][2]

Product and Technology

Jarvis sends one question to five AI models at once. It reconciles their responses into one answer and scores confidence from their agreement. People can try it without signing up. [1]

Nodes Bio describes its graph-rendering challenge as NP-complete and reports 12-second generation of publication-quality biological pathway diagrams. The platform is protected by U.S. Patents No. 10,176,442 and 10,997,540. [3][1]

Health uses an existing MyChart login to produce a plain-language summary of the user's medical record. It requires no account, provides read-only access and stores nothing on Nodes Bio servers. [3]

Jarvis Stats Lab turns pasted R output, including ANOVA and Tukey HSD results, into a publication-ready statement in 30 seconds across five models. [3]

Its iPhone and iPad catalog includes Jarvis: Multi-Model AI and Nexus Research: 5 AI Consensus. [4]

Milestones

Scroll table to see all columns →

DateWhat happenedSourceCoverage
Oct 28, 2026Nodes Bio launched Health, a free medical-record summary application.[3]—
Mar 3, 2026Nodes Bio launched Jarvis for medical professionals.[3]—
Jan 31, 2026Nodes Bio completed a real-time biological network visualization solution.[3]—
Jan 30, 2026Nodes Bio met with Dublin Economic Development about an anchor-tenant role in an Ohio life-sciences readiness application.[3]—
Jan 26, 2026Nodes Bio reached a paying customer while participating in the Rev1 Ventures accelerator.[3]—
Jan 15, 2026Nodes Bio applied its patent portfolio to biological network visualization.[3]—

We wrote this summary from public statements by Nodes Bio and its investors. It is not investment advice.

Sources

  1. CompanyNodes Bio home page · linked above ↑
  2. CompanyNodes Bio privacy policy
  3. CompanyNodes Bio press center
  4. CompanyNodes Bio App Store developer page
  5. SECNodes Bio Form D, filed 2026-11-19 · linked above ↑
  6. SECNodes Bio, Inc. filing history